CDK2 and Hodgkins lymphoma: Previous studies have shown that CNF2024 induced G2 cell cycle arrest in Hodgkin’s lymphoma cells [58] and decreased cell cycle-related proteins, including CDK1, CDK2, and cyclin D3, along with either G1 or G2 cell cycle arrest in multiple lymphoma cell lines [74].